Custom Pharma Services Adds New Location to Expand Manufacturing and Development Operations
Custom Pharma Services , a leading full-service contract development and manufacturing organisation (CDMO), has acquired a new building to expand its high containment manufacturing and development operations.
The new facility, the Custom Pharmaceutical Innovation Centre, is co-located on the Fairway Trading Estate in Brighton, adjacent to the company’s existing packaging and warehousing operations. Acquisition of this site will allow Custom Pharma Services to increase its capacity for clinical and product development of highly potent molecules and advance its commercial manufacturing capabilities with high containment capabilities to meet customer demand.
“Since 1979, Custom Pharma Services has provided solid dose manufacturing and development services. We offer our customers a full range of services, from clinical to commercial, including design of process and formulation development prototypes, stability and analytical testing, certification, contract manufacturing, primary packaging, shipment, consultancy and customer support,” said Nigel Richardson , CEO of Custom Pharma Services.
“Later this year, we plan to commence work on the building. This expansion is a tremendous opportunity to consolidate our operations and concentrate on broadening our scope of services,” said Richardson. “Custom Pharma has earned a reputation for providing dependable customer support and innovative products. This is a big step, enabling us to deliver a wider range of services aligned with current industry requirements.”
Custom Pharma Services will be exhibiting at CPhI Worldwide in Barcelona, Spain, 4-6 October. Stop by Booth 3B48 or schedule a meeting with Custom Pharma Services experts to find out how the company can take your compound from clinical and product development to full-on commercialisation.
About Custom Pharma Services
Custom Pharma Services is a full-service contract development and manufacturing organisation for investigational medicinal products. We provide the full spectrum of services for process development through commercial manufacturing. Our advanced facilities produce tablets, caplets, capsules (immediate and modified release) and powders for both clinical and commercial use. Fully certified in the UK and Europe, Custom Pharma Services is your one-stop resource for contract development and pharmaceutical manufacturing.
Lea Studer, +1 308-237-5567
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
NY-GTIS-PARTNERS20.9.2017 15:34 | pressemeddelelse
GTIS Partners Clinches Sustainability Performance Top Honors for Third Year Running
PA-MEET-GROUP20.9.2017 14:33 | pressemeddelelse
The Meet Group to Acquire LOVOO
ARTHUR-D.-LITTLE20.9.2017 13:02 | pressemeddelelse
Arthur D. Little Urges Network Operators to Prepare for Next-Generation Internet of the GigaWorld
LINTEC-CORPORATION20.9.2017 12:47 | pressemeddelelse
LINTEC Announces Four New Adhesive Materials for Labels
QUINTIQ20.9.2017 12:07 | pressemeddelelse
EGS Invests in Artificial Intelligence from Quintiq
FL-SES20.9.2017 11:05 | pressemeddelelse
EchoStar 105/SES-11 Shipped from Toulouse to the Cape for SpaceX Launch
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum